Also trades as: KLTOW (NASDAQ) · $vol 0M
KLTO NASDAQ
Klotho Neurosciences, Inc.
1W: -19.0%
1M: +75.0%
3M: -10.0%
YTD: +19.4%
1Y: +36.3%
$0.38
Last traded 2026-03-16 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$20.1M
52W Range0.114-3.91
Volume95,000
Avg Volume3,231,766
Beta2.23
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJoseph A. Sinkule
Employees3
SectorHealthcare
IndustryBiotechnology
IPO Date2022-04-29
Websitegreenlandmines.com
13576 Walnut Street
Omaha, NE 68144
US
Omaha, NE 68144
US
833 931 6330
About Klotho Neurosciences, Inc.
Klotho Neurosciences, Inc. operates as a biopharmaceutical enterprise focused on devising medical treatments for various conditions, including cancer, cardiovascular ailments, and neurodegenerative disorders. Their leading gene therapy assets encompass AMI-101, which is designed for the management or prevention of Alzheimer's disease, and AMI-202, aimed at treating or averting amyotrophic lateral sclerosis. Formerly known as Anew Medical, Inc., the company underwent a name change to Klotho Neurosciences, Inc. in September 2024. The firm's main office is situated in Omaha, Nebraska.
Latest News
Klotho Neurosciences to rebrand as Greenland Mines
Klotho Neurosciences Expands Into Mining With Greenland Mines Deal
Klotho Neurosciences Expands Into Mining With Greenland Mines Deal
12 Health Care Stocks Moving In Friday's After-Market Session
Klotho Neurosciences (NASDAQ:KLTO) Initiates Development of the "Klotho Clock," a Diagnostic Biological Aging and Longevity Clock that Unlocks Health Testing Through Epigenetics and Artificial Intelligence (AI)
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| LeBlanc Jeff | A-Award | 2,500,000 | — | 2026-03-04 |
| El-Dada Riad Hussein | A-Award | 350,000 | — | 2026-03-04 |
| ZENTMAN SAMUEL M | A-Award | 350,000 | — | 2026-03-04 |
| Hirschman Shalom | A-Award | 350,000 | — | 2026-03-04 |
| McGarity Jon | A-Award | 350,000 | — | 2026-03-04 |